• Jan
  • Feb
  • Mar
  • Apr
  • May
  • Jun
  • Jul
  • Aug
  • Sept
  • Oct
  • Nov
  • Dec
  • All
24.12.2013

Pharmstandard completes reorganization.

Moscow, December 24, 2013 –  Pharmstandard OJSC (“Pharmstandard” or the “Company”), a...

More
19.12.2013

Pharmstandard announces registration of Sirturo® for MDR-TB

Moscow, December 19, 2013  — Russia’s leading pharmaceutical company Pharmstandard OJSC...

More
17.12.2013

Pharmstandard announces temporary suspension of trading activities of ordinary shares on the Moscow Stock Exchange as of December 17, 2013.

Moscow, December 17, 2013 –  Pharmstandard OJSC (“Pharmstandard” or the “Company”), a...

More
16.12.2013

Pharmstandard filed an application for OTCPharm PJSC state registration.

Moscow, December 16, 2013  – Pharmstandard OJSC (“Pharmstandard” or the “Company”), a...

More
13.11.2013

Pharmstandard OJSC will buy out 1 436 920 ordinary shares from its shareholders.

Moscow, November 13, 2013  – Pharmstandard OJSC (LSE: PHST LI, RTS: PHST RU) (the “Company” or...

More
24.10.2013

Pharmstandard OJSC reports 9M/3Q2013 sales results

Moscow, October 24, 2013 – Pharmstandard OJSC (LSE: PHST IL, RTS: PHST RU) (further “Pharmstandard” or...

More
21.10.2013

Notice of 9M/3Q2013 sales results – announcement date

Moscow , October 21, 2013 –  OJSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) (“Pharmstandard”)...

More
27.09.2013

Pharmstandard OJSC: EGM results

Moscow, September 27, 2013  – Pharmstandard OJSC (LSE: PHST LI, RTS: PHST RU) (the “Company” or...

More
20.09.2013

Update re: Extraordinary General Shareholder’s Meeting of Pharmstandard OJSC. Voting.

Moscow, September 20, 2013 - Pharmstandard OJSC (the “Company”) announces additional details for voting at...

More
17.09.2013

Update re: Spin-off

Moscow, September 17, 2013 - Pharmstandard OJSC (the “Company”) announces that it is considering a spin-off...

More
06.09.2013

Pharmstandard OJSC announces changes in Shareholder Structure.

Moscow, September 06, 2013 — Pharmstandard OJSC (LSE: PHST LI, MICEX-RTS: PHST RU)...

More
30.08.2013

Pharmstandard OJSC informs of changes in the Investor Calendar

Moscow, August 30, 2013 -Pharmstandard OJSC (LSE: PHST LI, MICEX-RTS: PHST RU) («Pharmstandard» or/and the...

More
28.08.2013

Pharmstandard OJSC reports 1H 2013 Financial Results (unaudited)

Moscow, Аugust 28, 2013 –Pharmstandard OJSC (LSE: PHST IL, RTS: PHST RU) reports 1H2013 unaudited Financial...

More
27.08.2013

Pharmstandard Commits $30 Million to Argos Therapeutics Inc.

Moscow, August 27, 2013 – Pharmstandard OJSC (LSE: PHST LI, MICEX-RTS: PHST RU) (“Pharmstandard” or/and...

More
26.08.2013

Notice of 1H2013 Financial Results (unaudited) – announcement date

Moscow   , 26 August 2013 – Pharmstandard OJSC (LSE: PHST LI, RTS: PHST RU) will be announcing its 1H2013...

More
22.08.2013

Pharmstandard OJSC announces the closure of the transaction to acquire a stake in DONELLE COMPANY LIMITED

Moscow, August 22, 2013 – Pharmstandard OJSC (LSE: PHST IL, RTS: PHST RU) (further “Pharmstandard” or...

More
22.08.2013

Pharmstandard OJSC announces the completion of the transaction to acquire Bever Pharmaceutical PTE Ltd (Singapore)

Moscow, August 22, 2013 – Pharmstandard OJSC (LSE: PHST IL, RTS: PHST RU) (further “Pharmstandard” or...

More
19.08.2013

Pharmstandard OJSC announces EGM results

Moscow, August 19, 2013  – Pharmstandard OJSC (LSE: PHST LI, RTS: PHST RU) announces the results of its...

More
13.08.2013

Pharmstandard OJSC agrees key terms of a potential acquisition of Bever Pharmaceutical PTE Ltd (Singapore)

Moscow, August 13, 2013 – Pharmstandard OJSC (LSE: PHST IL, RTS: PHST RU) (“Pharmstandard” or the...

More
12.08.2013

Pharmstandard OJSC announces the acquisition of a 10.87% stake in DONELLE COMPANY LIMITED.

Moscow, August 12, 2013 – Pharmstandard OJSC (LSE: PHST IL, RTS: PHST RU) (further “Pharmstandard”)...

More
25.07.2013

Pharmstandard OJSC reports its 1H2013 sales results

Moscow, July 25, 2013 – Pharmstandard OJSC (LSE: PHST IL, RTS: PHST RU) (further “Pharmstandard” or the...

More
23.07.2013

Notice of 1H 2013 sales results – announcement date

Moscow , 23 July 2013 – OJSC Pharmstandard (LSE: PHST LI, RTS: PHST RU) will be announcing its 1H 2013 Sales...

More
17.07.2013

Update on Pharmstandard buy-back program.

HTML-редакторПеренос слов Moscow, July 17, 2013 — Pharmstandard OJSC (LSE: PHST LI, MICEX-RTS: PHST RU)...

More
16.07.2013

Update on Pharmstandard buy-back program.

Moscow, July 16, 2013 — Pharmstandard OJSC (LSE: PHST LI, MICEX-RTS: PHST RU) («Pharmstandard» or/and...

More
15.07.2013

Update on Pharmstandard buy-back program.

Moscow, July 15, 2013 — Pharmstandard OJSC (LSE: PHST LI, MICEX-RTS: PHST RU) («Pharmstandard» or/and...

More
12.07.2013

Update on Pharmstandard buy-back program.

Moscow, July 12, 2013 — Pharmstandard OJSC (LSE: PHST LI, MICEX-RTS: PHST RU) («Pharmstandard» or/and...

More
11.07.2013

Update on Pharmstandard buy-back program.

Moscow, July 11, 2013 — Pharmstandard OJSC (LSE: PHST LI, MICEX-RTS: PHST RU) («Pharmstandard»...

More
09.07.2013

Notice of Pharmstandard Investor Conference Call details

Moscow , July 9, 2013, –  OJSC Pharmstandard (Pharmstandard JSC (LSE: PHST IL, MICEX\RTS (main):PHST,...

More
09.07.2013

Pharmstandard OJSC specifies details on a possible acquisition

Moscow, 9 July 2013 - Pharmstandard OJSC (LSE: PHST IL, RTS: PHST RU) (“Pharmstandard” or the...

More
08.07.2013

Pharmstandard OJSC announces the extraordinary shareholder meeting in anticipation of a possible acquisition

Moscow, 8 July 2013 – Pharmstandard OJSC (LSE: PHST IL, RTS: PHST RU) (“Pharmstandard” or the...

More
08.07.2013

OJSC Pharmstandard announces the decision of the Board of Directors on the spin-off

Moscow, 8 July 2013 – Pharmstandard OJSC (LSE: PHST IL, RTS: PHST RU) (“Pharmstandard” or the...

More
28.05.2013

Pharmstandard OJSC announces the acquisition of a 41.93% stake in "Biolek" PJSC (Ukraine).

Moscow, May 28, 2013 – Pharmstandard OJSC (LSE: PHST IL, RTS: PHST RU) announces the acquisition of 41.93% stake in...

More
28.05.2013

Pharmstandard OJSC announces the acquisition of a 41.93% stake in "Biolek" PJSC (Ukraine).

Moscow, May 28, 2013 – Pharmstandard OJSC (LSE: PHST IL, RTS: PHST RU) announces the acquisition of 41.93% stake in...

More
28.05.2013

Pharmstandard OJSC announces AGM results

Moscow, May 28, 2013  — Pharmstandard OJSC (LSE: PHST LI, RTS: PHST RU) announces the results of its...

More
07.05.2013

Update on Pharmstandard buy-back program.

Moscow, May 7, 2013 — Pharmstandard OJSC (LSE: PHST LI, MICEX-RTS: PHST RU) («Pharmstandard»...

More
29.04.2013

Pharmstandard OJSC reports 2012 audited Financial Results and 1Q2013 Sales Results

Pharmstandard OJSC reports 2012 audited Financial Results and 1Q 2013 Sales Results Moscow, April 29, 2013...

More
09.04.2013

Pharmstandard OJSC announces the Acquisition of a 100% stake in Pharmstandard International S.A.

Pharmstandard OJSC announces the Acquisition of a 100% stake in  Pharmstandard International S.A.  ...

More
05.04.2013

Pharmstandard OJSC Board of Directors approves agenda for Annual General Meeting of Shareholders.

Moscow, April 5, 2013 - Pharmstandard OJSC (LSE: PHST IL, RTS: PHST RU) (the “Company”) announced the results...

More
15.02.2013

Pharmstandard OJSC announces share buyback program

Moscow, February 15, 2013 – Pharmstandard OJSC (LSE: PHST LI, MICEX-RTS: PHST RU) Board of Directors approved a...

More
13.02.2013

PHARMSTANDARD announces 2012 full year sales results.

Moscow, February 13, 2013 - OJSC Pharmstandard (LSE: PHST IL, RTS: PHST RU) announces unaudited consolidated sales...

More
12.02.2013

Notice of Pharmstandard Full Year 2012 sales update announcement date

Moscow , February 12, 2013, –  OJSC Pharmstandard (Pharmstandard JSC (LSE: PHST IL, MICEX\RTS (main):PHST,...

More

Media Contacts



Alexey Chernushkin


Chief Investment Officer, Pharmstandard JSC

+7 (495) 970 0030
+7 (495) 970 0032
ir@pharmstd.ru

5B, Likhachyovsky Proezd, Dolgoprudny, Moscow Region, 141701, Russia

+7 (495) 970 0030/32

16+

© 2007–2017

All rights reserved. JSC Pharmstandard.
Terms of use Disclosure of information.

ПРЕДУПРЕЖДЕНИЕ

Информация на сайте предназначена исключительно для медицинских работников.

Подтвердите, пожалуйста, являетесь ли Вы медицинским работником.

Если Вы не являетесь медицинским работником, пожалуйста, покиньте данный раздел сайта.


СОГЛАШЕНИЕ О ПОЛУЧЕНИИ ИНФОРМАЦИИ О РЕЦЕПТУРНЫХ ПРЕПАРАТАХ

1.На сайте представлена информация о рецептурных препаратах, их свойствах, способах применения и возможных противопоказаниях исключительно специалистам здравоохранения (лицам, имеющим высшее или среднее специальное медицинское образование).

2. Если Вы являетесь специалистом здравоохранения и хотите получить информацию с данного раздела сайта, Вам необходимо подтвердить ваш статус специалиста здравоохранения.

3. В случае если Вы не являетесь специалистом здравоохранения, но в нарушение настоящих условий подписываете данное соглашение, сайт Компании не несет ответственности за возможные отрицательные последствия, возникшие в результате самостоятельного использования Вами информации с сайта, без предварительной консультации со специалистом. Вы делаете это самостоятельно и осознанно, понимая, что применение рецептурных препаратов возможно только после предварительной консультации со специалистом здравоохранения.

4. Информация о рецептурных препаратах, представленная на данном разделе сайте, предназначена исключительно для ознакомления с препаратами и не является руководством для самостоятельной диагностики или лечения, и не служит в качестве медицинских советов или рекомендаций. Сайт не несет ответственности за возможный ущерб, нанесенный Вашему здоровью в случае самовольного лечения, проводимого на основании применения рецептурных препаратов (без предварительной консультации со специалистом). Настоящим я подтверждаю, что являюсь специалистом здравоохранения и подтверждаю своё согласие с тем, что применение рецептурных препаратов возможно только после предварительной консультации со специалистом.